The clinical pharmacology of 5-trifluoromethyl-2'-deoxyuridine.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000378:metabolism* / Q000494:pharmacology / Q000652:urine; D002245:Carbon Dioxide / Q000032:analysis; D002247:Carbon Isotopes; D006528:Carcinoma, Hepatocellular / Q000652:urine; D002986:Clinical Trials as Topic; D005260:Female; D005354:Fibrosarcoma / Q000652:urine; D005459:Fluorides / Q000652:urine; D006207:Half-Life; D006689:Hodgkin Disease / Q000652:urine; D006801:Humans; D007938:Leukemia / Q000652:urine; D008113:Liver Neoplasms; D008297:Male; D008875:Middle Aged; D009447:Neuroblastoma / Q000652:urine; D009705:Nucleosides / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology / Q000652:urine; D012175:Retinoblastoma / Q000652:urine; D014498:Uracil / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology / Q000652:urine
D000970:Antineoplastic Agents; D002247:Carbon Isotopes; D009705:Nucleosides; D002245:Carbon Dioxide; D014498:Uracil; D005459:Fluorides